[First clinical trials of treatment of primary liver cancer with immunostimulating agents administered by systemic or intratumoral route].
D002759:Adenoma, Bile Duct / Q000628:therapy; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000942:Antigens, Bacterial / Q000008:administration & dosage; D001500:BCG Vaccine / Q000627:therapeutic use*; D001410:Bacillus megaterium / Q000276:immunology; D006528:Carcinoma, Hepatocellular / Q000628:therapy; D010478:Chemotherapy, Cancer, Regional Perfusion; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011425:Propionibacterium acnes / Q000276:immunology
D000276:Adjuvants, Immunologic; D000942:Antigens, Bacterial; D001500:BCG Vaccine
Premiers essais cliniques de traitement du cancer primaire du foie par des agents immunostimulants administrés par voie systémique ou intra-tumorale